Merck KGaA Acquires Cell Culture Media Specialist Biochrom AG
News Aug 24, 2012
EMD Millipore has announced that it has entered into definitive agreements to acquire Biochrom AG located in Berlin, Germany.
The company, with approximately 60 employees and sales of approximately € 13 million in 2011, specializes in the production and marketing of cell-culture media and buffer solutions.
The parties agreed not to disclose the purchase price. The acquisition is subject to customary closing conditions such as the approval of the respective antitrust authority.
Closing of the transaction is expected in the fourth quarter of 2012.
The acquisition will strengthen EMD Millipore’s Process Solutions business unit, which provides products, services and solutions that simplify production complexity for pharmaceutical and biopharmaceutical manufacturers.
Biochrom’s cell-culture media products are highly complementary and innovative, adding liquid cell-culture media and buffers including serum-free products and disposable packaging solutions to the existing portfolio.
“With Biochrom we have a great opportunity to deliver an expanded portfolio of cell-culture media products to our global customers and address a growing demand for ready-to-use liquid solutions that drive safety and efficiency in the development and manufacture of clinical and commercial drug materials,” said Robert Yates, head of the EMD Millipore division.
Dr. Bernd Frenzel, CEO of Biochrom AG, said: “EMD Millipore is the ideal partner for Biochrom. With EMD Millipore we will be able to leverage their industry relationships and global footprint to reach more customers and offer a more comprehensive portfolio of media and buffers”.
It is planned to maintain Biochrom’s operations in Berlin. Biochrom’s activities will be part of EMD Millipore’s Process Solutions business unit.
New Class of Drugs for the Treatment of Advanced Lung DiseaseNews
Researchers have demonstrated the potential of a new class of drugs for the treatment of refractory chronic obstructive pulmonary disease, i.e. COPD.READ MORE
Heart-muscle Patches Created from Human Cells Improve Recovery from Heart AttacksNews
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery from heart attack injury.READ MORE
Researchers Identify Druggable Genomic Targets in Malaria ParasiteNews
Using whole-genome analysis and chemogenomics, scientists have discovered novel antimalarial drug targets and drug-resistance genes. The researchers analyzed >250 Plasmodium falciparum cell lines, which were resistant to 37 different anti-malarial compounds.READ MORE